Expertise in
1
conditions

Mark B. Smithers

Brisbane, QLD, AU 
Expertise in
1
conditions
Brisbane, QLD, AU 

Overview

Mark Smithers practices practicing medicine in Brisbane, Australia.

Mr. Smithers is highly rated in 1 condition, according to our data. His clinical expertise encompasses Melanoma, Esophageal Cancer, and Neuroendocrine Tumor.

He is actively involved in clinical research, co-authoring 21 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Brisbane, QLD, Australia
Other Locations
Woolloongabba, QLD, Australia
QLD, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 1b/2 Study of PV-10 Intralesional Injection in Combination With Systemic Immune Checkpoint Inhibition for Treatment of Metastatic Melanoma
A Phase 1b/2 Study of PV-10 Intralesional Injection in Combination With Systemic Immune Checkpoint Inhibition for Treatment of Metastatic Melanoma
Enrollment Status: Unknown
Publish Date: November 21, 2023
Intervention Type: Drug
Study Drugs: PV-10, Pembrolizumab
Study Phase: Phase 1/Phase 2
PV-10 Intralesional Injection vs Systemic Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma
PV-10 Intralesional Injection vs Systemic Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma
Enrollment Status: Terminated
Publish Date: January 19, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase I, Open Label, Cohort Study of Two Doses of Cavatak (Coxsackievirus Type A21) Given Intratumourally in Stage IV Melanoma Patients.
A Phase I, Open Label, Cohort Study of Two Doses of Cavatak (Coxsackievirus Type A21) Given Intratumourally in Stage IV Melanoma Patients.
Enrollment Status: Completed
Publish Date: July 01, 2019
Intervention Type: Drug
Study Phase: Phase 1
View 2 Less Clinical Trials

21 Total Publications

Open Versus Hybrid and Total Minimally Invasive Transthoracic Ivor Lewis Esophagectomy Following Neoadjuvant FLOT Chemotherapy: An Australian and New Zealand Cohort Study.
Open Versus Hybrid and Total Minimally Invasive Transthoracic Ivor Lewis Esophagectomy Following Neoadjuvant FLOT Chemotherapy: An Australian and New Zealand Cohort Study.
Journal: World journal of surgery
Published: February 24, 2026

Frequently Asked Questions about Mark B. Smithers

Is Mark B. Smithers a top-rated expert for Melanoma?

MediFind is an objective health platform that identifies experts based on real-world data. Mark B. Smithers is classified as an Distinguished expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mark B. Smithers participate in research or clinical trials?

Yes. Mark B. Smithers has published 21 articles and abstracts on conditions like Melanoma. You can view a list of Mark B. Smithers's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Smithers's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile